Please note: no videos are available for the ICPAD presentations
Meeting category
Date(s)
21 Nov 2019 - 22 Nov 2019
Location
Amsterdam,
Netherlands
Organizer
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Related Enduring Materials
Enduring Materials
Downloads:
Program
Day 1 - Thursday, 21 November 2019
Session 1: Redesigning studies and endpoints with immuno oncology -
Chairs
Changes and Challenges in Early Phase Trial Endpoints
New Designs for Early Clinical Trials of IO Drugs
Session 2: Imaging, genetics and environment -
Chairs
The Use of Radiolabeled and Fluorescent Monoclonal Antibodies for Molecular Imaging in Oncology
The Long and Winding Road of the Clinical Introduction of a Biomarker
Abstract-driven presentations -
Epigenetic Regulation of OCTN1-mediated Cytarabine Transport in Acute Myeloid Leukemia
Comprehensive Pan-Cancer Analysis of Somatic Mutations in Drug Transporters to Reveal Acquired and Intrinsic Drug Resistance in 3149 Metastatic Cancer Patients
Session 3: PK/PD studies and new strategies -
Chairs
How System Pharmacology Can Facilitate Clinical Drug Development in Oncology
Impact of Immortal Time and Selection Bias on Exposure-response Modelling
Clinical Pharmacology Strategy for Development and Labelling of New Medicine in the Era of Targeted Therapy and Accelerated Approvals in Oncology
Abstract-driven presentations -
Quantitative Modelling of Inter-lesion and Inter-organ Variability of Tumor Size
Sreenath Krishnan
Sweden
Population Pharmacodynamics Modelling of Circulating Lymphocyte Count Over Time in Chronic Lymphocytic Leukemia Patients Under Ibrutinib Treatment
Day 2 - Friday, 22 November 2019
Session 4: Optimal study design & biomarker selection and validation -
Chairs
Optimal Study Design of Oncology Trials
Challenges in the Development of Immunotherapy
Abstract-driven presentations -
Pharmacokinetics and Safety of Pazopanib in Frail Elderly Patients
Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Adrenocortical Carcinoma Patients: Towards Individualized Dosing
Anyue Yin
Netherlands
Session 5: Drug-Drug / Drug-Food / Drug-environmental interactions -
Chairs
Drug - Food Interaction: An Unrealized Potential
Challenges in Treating Geriatric Patients With Cancer
Abstract-driven presentations -
Modulation of CYP3A activity to Increase the Oral Bioavailability of Ibrutinib
Eric Eisenmann
USA
Effects of Dietary Restriction in Cancer Patients Receiving Irinotecan
Session 6: Dose individualization approaches -
Chair
Dose Individualization Potential for Oral Targeted Oncolytics
Dose Individualization Potential for Checkpoint Inhibitors
Overview
Welcome
We are pleased to look back on a very successful the 4th International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD), held on the 21st and 22nd November 2019 in Amsterdam, the Netherlands.
The Organizing Committee and organizers would like to thank the speakers, chairs and all participants for their contribution to this meeting! Special thanks to the workshop sponsors: Daiichi Sankyo, Inc., Boehringer Ingelheim, Pfizer Oncology, and Celgene. Without their contributions this workshop would not have been possible.
The slides of the presentations given during the meeting, provided the speaker's consent was received, are available here.
We look forward to seeing you again at the next International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD).
The Organizing Committee
Support
Bronze Level
Media
Image
